Navigation Links
Commentary in The Lancet on the Declaration of Istanbul Sees Organ Transplantation Worldwide Threatened by Organ Trafficking and Transplant Tourism and Commercialism

BOSTON, Massachusetts, July 3 /PRNewswire/ -- The July 5 issue of the leading medical journal, The Lancet, highlights the Declaration of Istanbul on Organ Trafficking and Transplant Tourism, an important affirmation of ethical principles and practices adopted on May 2, 2008, at an International Summit of more than 150 healthcare professionals, officials, scientists, ethicists and legal scholars from 78 countries and 20 international organizations. A Commentary, authored by the 32-member Steering Committee of the Istanbul Summit, describes how the policies advocated by the Declaration will help to combat the trafficking of people as a source of human organs for transplantation, and the transplant tourism which depends on organ sales and undermines countries' efforts to meet the health needs of their own populations. The commentary and the declaration are available at the following Multimedia News release link, please click:

Organ commercialism, which targets vulnerable populations (such as illiterate and impoverished persons, undocumented immigrants, prisoners, and political or economic refugees) in resource-poor countries, has been condemned by international bodies such as the World Health Organization for decades. Yet in recent years, as a consequence of the increasing ease of internet communication and the willingness of patients in rich countries to travel and purchase organs, organ trafficking and transplant tourism have grown into global problems. For example, as of 2006, foreigners received two-thirds of the 2000 kidney transplants performed annually in Pakistan.

The Declaration of Istanbul proclaims that the poor who sell their organs are being exploited, whether by richer people within their own countries or by transplant tourists from abroad. Moreover, transplant tourists risk physical harm by unregulated and illegal transplantation. Participants in the Istanbul Summit concluded that transplant commercialism and tourism and organ trafficking should be prohibited. And they also urged their fellow transplant professionals, individually and through their organizations, to put an end to these unethical activities and foster safe, accountable practices that meet the needs of transplant recipients while protecting donors.

The Commentary points out that countries from which transplant tourists originate, as well as those to which they travel to obtain transplants, are just beginning to address their respective responsibilities to protect their people from exploitation and to develop national self-sufficiency in organ donation. The authors expect that the Declaration will reinforce the resolve of governments and international organizations to develop laws and guidelines to bring an end to wrongful practices. "The legacy of transplantation is threatened by organ trafficking and transplant tourism. The Declaration of Istanbul aims to combat these activities and to preserve the nobility of organ donation. The success of transplantation as a life-saving treatment does not require-nor justify-victimizing the world's poor as the source of organs for the rich."

The Declaration of Istanbul has been endorsed by The Transplantation Society and the International Society of Nephrology, which sponsored the Summit meeting.

SOURCE The Transplantation Society
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. The Lancet Global Health Network
2. The Lancet publishes first clinical trial data of a fully bioabsorbable drug-eluting stent
3. MediPurpose Sells 500 Millionth Safety Lancet to IMCO Member MMS Medical
4. New Lancet Study: Tobacco Control Measures Are Effective and Affordable Strategies to Reduce Chronic Disease Deaths Globally
5. Two studies published in the Lancet
6. Telecommunications Carriers Respond To Congress Declaration of April as National 9-1-1 Education Month
7. Figure Skater Peggy Fleming Teams With HealthSaver: Go Organic for Quality, Natural Food
8. Organ Donation: An Advancing Science Hindered by Supply Shortages
9. Latest Research Shows Strong Consumer Demand for Organic Foods
10. Immune Molecule Key to Preventing Organ Rejection
11. Target Debuts Organic Skin Care Line Uniquely Developed from African and Asian Natural Remedies
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... On Tuesday 27 ... NASDAQ to educate the personnel on spinal decompression therapy and offer his professional ... nonsurgical procedure. The benefits come from creating negative intradiscal pressure which is conducive ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... rural West Tennessee to receive Gigabit Internet through a partnership this year with ... largest cities, Henderson is an attractive destination for entrepreneurs who want to build ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... Florida Hospital Tampa is the ... of obesity in the state of Florida. , vBloc® Therapy is a vagal blocking therapy, ... 18 years with a body mass index (BMI) of at least 40 to 45 kg, ...
(Date:12/1/2015)... ... ... Califia Farms , one of the fastest growing natural beverage companies ... in Beverage World Magazine’s Global Packaging Design Awards, taking home the Gold in the ... a 2015 U.S.A. Taste Champion in the American Masters of Taste Championships for its ...
(Date:12/1/2015)... ... December 01, 2015 , ... December 1, 2015 ... of the company’s growing product line of food safety and seafood fraud prevention ... (Oncorhynchus nerka) – allow InstantLabs to offer fast, reliable species identification for the ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... WellStar Health System has signed a definitive ... Tenet Healthcare,s five metro Atlanta ... move following the conclusion of the due diligence period. ... and patient safety programs that have resulted in increased ... --> --> With ...
(Date:12/1/2015)... 2015  Eyeon Therapeutics has received a Notice ... based on a charged hydrophilic polymer developed at ... product has been shown to be safe and ... Mark Mitchnick , MD, CEO states, "This second ... polymers in conjunction with a therapeutic agent.  Nanoparticles ...
(Date:12/1/2015)... , Dec. 1, 2015 Pharma Tech Outlook ... Top 10 Clinical Data Management Solution Providers - 2015 ... distinguished panel comprising CEOs, CIOs, VCs, analysts, and the ... illustrious list of top 10 clinical data management solution ... on pages 14 and 36 respectively). ...
Breaking Medicine Technology: